收藏本站
收藏 | 投稿 | 手机打开
二维码
手机客户端打开本文

Influences of etiology and endoscopic appearance on the long-term outcomes of gastric antral vascular ectasia

Hyo Jin Kwon  Si Hyung Lee  Joon Hyun Cho  
【摘要】:BACKGROUND Gastric antral vascular ectasia(GAVE) has diverse associations and presumed causes, which include liver cirrhosis, chronic kidney disease, and autoimmune disease. This heterogeneity of underlying disorders suggests that the pathogenesis of GAVE may be variable.AIM To compare the clinical features and long-term outcomes of GAVE according to endoscopic patterns and etiologies.METHODS The medical records and endoscopic images of 23 consecutive patients diagnosed with GAVE by endoscopy at Yeungnam University Hospital from January 2006 to December 2020 were retrospectively reviewed. Patients were allocated to cirrhosis(16 patients) and non-cirrhosis groups(7 patients). GAVE subtypes, as determined by endoscopy, were categorized as punctate(a diffuse, honeycomb-like appearance, 17 patients) or striped(a linear, watermelon-like appearance, 6 patients).RESULTS All GAVE patients with cirrhosis(16/16, 100%) had a punctate pattern by endoscopy, whereas the majority of patients(6/7, 85.7%) without cirrhosis had a striped pattern(P 0.001). Overt GAVE bleeding(10/23, 43%) was significantly more common in the non-cirrhosis group than in the cirrhosis group(6/7, 85.7% vs 4/16, 25.0%; P = 0.019), and more common in the striped group than in the punctate group(5/6, 83.3% vs 5/17, 29.4%; P = 0.052). However, mean numbers of admissions due to GAVE bleeding and argon plasma coagulation(APC) sessions to address overt bleeding were similar in the cirrhosis and non-cirrhosis groups and in the punctate and striped groups. All patients with GAVE bleeding were successfully treated by APC, and no patient died from GAVE-related blood loss during a median follow-up of 24 mo.CONCLUSION Punctate-type GAVE is strongly associated with liver cirrhosis, and GAVE patients without cirrhosis tend to be more prone to overt bleeding. However, the presence of cirrhosis and endoscopic patterns did not influence long-term clinical courses or outcomes in cases of overt bleeding.

知网文化
【相似文献】
中国期刊全文数据库 前20条
1 Lucia Cerrito;Maria Elena Ainora;Alberto Nicoletti;Matteo Garcovich;Laura Riccardi;Maurizio Pompili;Antonio Gasbarrini;Maria Assunta Zocco;;Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals[J];World Journal of Hepatology;2021年11期
2 Jaros?aw Jerzy Sak;Andrzej Prystupa;Pawe? Kiciński;Dorota Luchowska-Kocot;Ewa Kurys-Denis;Hanna Bis-Wencel;;Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis[J];World Journal of Hepatology;2021年12期
3 Asim Kichloo;Zain El-Amir;Dushyant Singh Dahiya;Farah Wani;Jagmeet Singh;Dhanshree Solanki;Ehizogie Edigin;Precious Eseaton;Asad Mehboob;Hafeez Shaka;;Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions[J];World Journal of Hepatology;2021年12期
4 Ji Lin;Jian-Feng Wu;Qi Zhang;Hong-Wei Zhang;Guang-Wen Cao;;Virus-related liver cirrhosis: Molecular basis and therapeutic options[J];World Journal of Gastroenterology;2014年21期
5 Xing Wang;Shang-Xiong Lin;Jin Tao;Xiu-Qing Wei;Yuan-Ting Liu;Yu-Ming Chen;Bin Wu;;Study of liver cirrhosis over ten consecutive years in Southern China[J];World Journal of Gastroenterology;2014年37期
6 李培杰;;Comparison of five-year survival status of patients with liver cirrhosis and esophagogastric varices bleeding treated by transjugular intrahepatic portosystemic shunt and drug combined with endoscopic treatment[J];China Medical Abstracts(Internal Medicine);2021年04期
7 Mitchell L Ramsey;Michael R Wellner;Kyle Porter;Stephen E Kirkby;Susan S Li;Luis F Lara;Sean G Kelly;A James Hanje;Lindsay A Sobotka;;Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis[J];World Journal of Hepatology;2022年02期
8 Roman Maslennikov;Vladimir Ivashkin;Irina Efremova;Elena Poluektova;Anna Kudryavtseva;George Krasnov;;Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis[J];World Journal of Gastroenterology;2022年10期
9 Shaiane Ferreira;Cláudio Augusto Marroni;Jessica Taina Stein;Roberta Rayn;Ana Cristhina Henz;Natália P Schmidt;Randhall B Carteri;Sabrina Alves Fernandes;;Assessment of resting energy expenditure in patients with cirrhosis[J];World Journal of Hepatology;2022年04期
10 Li-Xing Chen;Si-Juan Zou;Dan Li;Jian-Yuan Zhou;Zhao-Ting Cheng;Jun Zhao;Yuan-Li Zhu;Dong Kuang;Xiao-Hua Zhu;;Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis[J];World Journal of Gastroenterology;2020年48期
11 Xiao-Na Lin;Qiu-Xiong Lin;Shu-Mei Li;Ke-Ping Xie;Jun Hou;Ren Chen;;Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: A case report and review of literature[J];World Journal of Hepatology;2020年12期
12 Cristina Tocia;Andrei Dumitru;Luana Alexandrescu;Razvan Popescu;Eugen Dumitru;;Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis[J];World Journal of Hepatology;2020年12期
13 Ramesh Kumar;Rajeev Nayan Priyadarshi;Utpal Anand;;Chronic renal dysfunction in cirrhosis: A new frontier in hepatology[J];World Journal of Gastroenterology;2021年11期
14 Michelle Bernshteyn;Linda Hu;Umair Masood;Anuj Vikrant Sharma;Danning Huang;Bishnu Sapkota;;Retrospective analysis of complications related to endoscopic retrograde cholangio-pancreatography in patients with cirrhosis vs patients without cirrhosis[J];World Journal of Hepatology;2021年04期
15 Hung-Yuan Su;Yin-Chou Hsu;;Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives[J];World Journal of Clinical Cases;2021年13期
16 Roman Maslennikov;Vladimir Ivashkin;Irina Efremova;Aliya Alieva;Ekaterina Kashuh;Ekaterina Tsvetaeva;Elena Poluektova;Elena Shirokova;Konstantin Ivashkin;;Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis[J];World Journal of Hepatology;2021年05期
17 Kapil Gupta;Abhishek Bhurwal;Cindy Law;Scott Ventre;Carlos D Minacapelli;Savan Kabaria;You Li;Christopher Tait;Carolyn Catalano;Vinod K Rustgi;;Acute kidney injury and hepatorenal syndrome in cirrhosis[J];World Journal of Gastroenterology;2021年26期
18 LU Feng;GENG Jiabao;ZHANG Jiawei;DONG Yu;;Effect of entecavir plus Ganshuang granule(肝爽颗粒)on fibrosisand cirrhosis in patients with chronic hepatitis B[J];Journal of Traditional Chinese Medicine;2021年04期
19 Pallavi Surana;Julian Hercun;Varun Takyar;David E Kleiner;Theo Heller;Christopher Koh;;Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis[J];World Journal of Gastrointestinal Pathophysiology;2021年03期
20 Alberto E Mu?oz;Florencia D Pollarsky;Mónica Marino;Mariano Cartier;Horacio Vázquez;Pablo Salgado;Gustavo Romero;;Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy[J];World Journal of Gastroenterology;2021年28期
中国重要会议论文全文数据库 前20条
1 Li Yu;;A Novel Mechanism by which Gut Microbial Metabolite Sodium Butyrate Regulates Lipogenesis and NAFLD[A];第四届中国生物物理学会代谢生物学分会学术研讨会摘要集[C];2021年
2 Wei Li;Zheng Guan;Jean C Brisset;Qiaojuan Shi;Qi Lou;Yue Ma;Su Suriguga;Huazhong Ying;Xiaoying Sa;Zhenwen Chen;Wim J Quax;Xiaofeng Chu;;A nonalcoholic fatty liver disease cirrhosis model in gerbil:the dynamic relationship between hepatic lipid metabolism and cirrhosis[A];第十五届中国实验动物科学年会论文集[C];2019年
3 阳乔;朱永芬;吕芳芳;;Population-based study of the risk and early diagnostic tool for bacteremia in patients with liver cirrhosis[A];第十届全国疑难及重症肝病大会论文汇编[C];2019年
4 Fengmin Lu;Ling Zhang;Hui Zhuang;;Etiological and clinicopathological characteristics of cirrhosis and hepatocellularcarcinoma in the Henan province of China[A];中华医学会第三次全国肝纤维化、肝硬化学术会议论文汇编[C];2012年
5 张二雷;陈孝平;黄志勇;;Predicting the severity of liver cirrhosis through clinical parameters in patients with hepatitis B-related hepatocellular carcinoma[A];第十五届全国肝癌学术会议资料汇编[C];2015年
6 Maoyao Wen;Ruoting Men;Yongjun Zhu;Xuelian Dan;Wenchao Wu;Xiaojing Liu;Li Yang;;Circulating Nogo-B are correlated with liver cirrhosis[A];第十七届西南地区消化病学术会议暨2014贵州省消化病及消化内镜学术年会论文汇编[C];2014年
7 Yu-dong Xiao;Cong Ma;Jun Liu;Hua-bing Li;Bin Zhang;Huan Liu;Han-lin Fu;Jiang-bei Deng;Wei-qian Lu;Shun-ke Zhou;;Chronic cirrhosis-related splenic artery steal syndrome:evaluation by using proper hepatic artery to splenic artery ratio and Gd-EOB-DTPA-enhanced MR[A];第四届全国医学影像中西医结合青年医师论坛暨第四届《中国中西医结合影像学杂志》编委会会议资料汇编[C];2015年
8 吴传勇;娄加陶;韩志君;蒋廷旺;邓安梅;仲人前;;肿瘤坏死因子受体相关因子在原发性胆汁性肝硬化患者外周血单个核细胞的表达及临床意义[A];全国临床免疫检验研讨会暨第六届全国临床免疫学术会议论文汇编[C];2009年
9 ;Midwall Fractional Shortening Early Evaluate Left Heart Function in liver cirrhosis[A];中华医学会第十次全国超声医学学术会议论文汇编[C];2009年
10 韩志君;;肿瘤坏死因子受体相关因子在原发性胆汁性肝硬化患者外周血单个核细胞的表达及临床意义[A];中华医学会第八次全国检验医学学术会议暨中华医学会检验分会成立30周年庆典大会资料汇编[C];2009年
11 Micheal Wells;;To Understand Hepatorenal Syndrome from Basic Integrative TCM and Mordern Medicine Study[A];2011·中国医师协会中西医结合医师大会论文集[C];2011年
12 ;High levels of FCgamaR3A and PRF1 expression in NK and NKT cells from patients with primary biliary cirrhosis[A];中华医学会第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议论文汇编[C];2011年
13 Jian Sun;Jinlin Hou;;Individulised Treatment of Chronic Hepatitis B in China[A];2012中国消化系疾病学术大会论文汇编[C];2012年
14 JieWang;PengGu;;A Clinical Study Of Left Ventricular Function In Patients With Cirrhosis During Different Periods By Ultrasonography[A];中华医学会第十三次全国超声医学学术会议论文汇编[C];2013年
15 hong zhang;;The clinical research of the relationship between nutrition status with prognosis in liver cirrhosis[A];中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编[C];2013年
16 Xiliu Chen;Liping Sun;Xiaoling Yi;Shenghua Jie;;microRNA expression profiles derived from microvesicles and their functional roles in liver cirrhosis patients[A];中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编[C];2013年
17 Zhijun Su;Xueping Yu;Ruyi Guo;Desong Ming;Lvye Huang;Milong Su;Yong Deng;Zhenzhong Lin;;The ratios of Treg/Th17 and TGF-β1/IL-17 are associated with the survival and disease progression in patients with HBV-associated liver cirrhosis[A];中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编[C];2013年
18 Samuel So;;Importance of a China National Liver Disease Prevention, Education,Treatment and Research Plan[A];第二届全国人工肝及血液净化学术年会论文集[C];2005年
19 Wen Jia;Xun Qi;Yanyan Ji;Hong Wang;Yuee Wang;Ting Wang;Jianhua Yang;Richeng Mao;Jiming Zhang;;Low serum hepatitis B surface antigen levels predict compensated cirrhosis caused by chronic hepatitis B[A];中华医学会第十三次全国感染病学术会议论文汇编[C];2014年
20 ;Peripheral Blood Gene Expression Profiles in Patients with Primary Biliary Cirrhosis[A];中华医学会第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议论文汇编[C];2011年
中国博士学位论文全文数据库 前7条
1 张磊;原发性胆汁性肝硬化发病机制和生物标志物的研究[D];北京协和医学院;2009年
2 陈佳宁;调节性T细胞在原发性胆汁性肝硬化中的免疫调节作用和机制研究[D];浙江大学;2016年
3 刘红虹;原发性胆汁性肝硬化的免疫发病机制和人脐带间充质干细胞治疗的安全性及有效性的研究[D];中国人民解放军医学院;2013年
4 史旭华;原发性胆汁性肝硬化的临床与基础研究及对治疗的反应[D];中国协和医科大学;2006年
5 石运莹;原发性胆汁性肝硬化药物治疗后的相关免疫学变化[D];中国协和医科大学;2008年
6 熊吉;代谢因素在住院肝硬化患者相关临床问题的回顾性研究[D];第三军医大学;2016年
7 孔芳;中国汉族人群原发性胆汁性肝硬化的候选基因研究[D];北京协和医学院;2011年
中国硕士学位论文全文数据库 前20条
1 任慧琼;78例原发性胆汁性肝硬化的临床分析[D];第二军医大学;2005年
2 PIYUSH KUMAR MISHRA;[D];重庆医科大学;2016年
3 胡世玲;AMA及其M2亚型对PBC诊断价值的Meta分析[D];重庆医科大学;2014年
4 陈芳;48例原发性胆汁性肝硬化的临床分析[D];中南大学;2009年
5 林慧佳;原发性胆汁性肝硬化的临床分析[D];浙江大学;2006年
6 张文忠;46例抗着丝点抗体阳性的原发性胆汁性肝硬化患者临床分析[D];新疆医科大学;2010年
7 唐海鸿;熊去氧胆酸联合通胆汤治疗原发性胆汁性肝硬化研究[D];广州中医药大学;2009年
8 周志博;住院肝硬化患者发生急性肝功能恶化的临床演变病程[D];浙江大学;2016年
9 邢浩;高密度脂蛋白胆固醇预测肝硬化门静脉血栓病人的预后的回顾性研究[D];河北医科大学;2020年
10 李晞;原发性胆汁性肝硬化外周血单个核细胞mRNA表达谱的差异分析及差异基因的表达验证[D];广西医科大学;2011年
11 柳婧美;中国人群PBC家系成员的发病情况及机制初探[D];第四军医大学;2008年
12 张艳;门静脉血栓在肝硬化急性失代偿患者中的临床特征、危险因素及预后分析研究[D];上海交通大学;2020年
13 吴依思;HBeAg阴性慢乙肝肝硬化患者临床指标的差异分析[D];华中科技大学;2020年
14 闫琪;原发性胆汁性胆管炎44例临床分析[D];苏州大学;2016年
15 刘晓丹;原发性胆汁性肝硬化合并干燥综合征的临床研究[D];山西医科大学;2009年
16 肖春桃;基于肝硬化数据库分析门静脉血栓对肝硬化患者预后的影响[D];西南医科大学;2021年
17 林国帅;肝硬化合并门静脉血栓形成的临床特点及相关危险因素分析[D];新疆医科大学;2016年
18 黄凤楼;PBC患者PBMCs中miR-20a-5p的表达及其功能研究[D];第二军医大学;2014年
19 朱丽;44例原发性胆汁性肝硬化的临床特征分析[D];中国医科大学;2010年
20 耿波;肝硬化门静脉高压症食管胃底静脉曲张的防治进展[D];重庆医科大学;2016年
 快捷付款方式  订购知网充值卡  订购热线  帮助中心
  • 400-819-9993
  • 010-62982499
  • 010-62783978